Cargando…

Beta Adrenergic Signaling: A Targetable Regulator of Angiosarcoma and Hemangiosarcoma

Human angiosarcomas and canine hemangiosarcomas are highly aggressive cancers thought to arise from cells of vascular origin. The pathological features, morphological organization, and clinical behavior of canine hemangiosarcomas are virtually indistinct from those of human angiosarcomas. Overall su...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dickerson, Erin B., Bryan, Brad A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2015
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5644640/ https://www.ncbi.nlm.nih.gov/pubmed/29061946 http://dx.doi.org/10.3390/vetsci2030270

Ejemplares similares

Targeting of Beta Adrenergic Receptors Results in Therapeutic Efficacy against Models of Hemangioendothelioma and Angiosarcoma
por: Stiles, Jessica M., et al.
Publicado: (2013)

Molecular subtypes in canine hemangiosarcoma reveal similarities with human angiosarcoma
por: Wang, Guannan, et al.
Publicado: (2020)

Pathobiology of Hemangiosarcoma in Dogs: Research Advances and Future Perspectives
por: Kim, Jong-Hyuk, et al.
Publicado: (2015)

Beta-adrenergic receptor blockade in angiosarcoma: Which beta-blocker to choose?
por: Embaby, Alaa, et al.
Publicado: (2022)

The beta adrenergic receptor antagonist propranolol alters mitogenic and apoptotic signaling in late stage breast cancer
por: Montoya, Alexa, et al.
Publicado: (2019)

Comparison of the oncogenomic landscape of canine and feline hemangiosarcoma shows novel parallels with human angiosarcoma
por: Wong, Kim, et al.
Publicado: (2021)

Genomic landscapes of canine splenic angiosarcoma (hemangiosarcoma) contain extensive heterogeneity within and between patients
por: Wong, Shukmei, et al.
Publicado: (2022)

Non-selective beta blockers inhibit angiosarcoma cell viability and increase progression free- and overall-survival in patients diagnosed with metastatic angiosarcoma
por: Amaya, Clarissa N., et al.
Publicado: (2018)

Constitutive expression and roles of interleukin-8 in canine hemangiosarcoma
por: Kim, Jong-Hyuk, et al.
Publicado: (2013)

Molecular Profile of Canine Hemangiosarcoma and Potential Novel Therapeutic Targets
por: Pimentel, Pedro Antônio Bronhara, et al.
Publicado: (2023)

Beta-adrenergic receptors are expressed across diverse cancers
por: Rains, Steven L., et al.
Publicado: (2017)

Hemangiosarcoma and its cancer stem cell sub-population are effectively killed by a toxin targeted through epidermal growth factor and urokinase receptors
por: Schappa, Jill T, et al.
Publicado: (2013)

PTEN haploinsufficiency and hemangiosarcoma
Publicado: (2012)

Actionable mutations in canine hemangiosarcoma
por: Wang, Guannan, et al.
Publicado: (2017)

Beta-Adrenergic Agonists
por: Barisione, Giovanni, et al.
Publicado: (2010)

Beta-adrenergic signaling, a novel target for cancer therapy?
por: Schuller, Hildegard M.
Publicado: (2010)

Aberrations in Angiogenic Signaling and MYC Amplifications are Distinguishing Features of Angiosarcoma
por: Kurisetty, Vittal, et al.
Publicado: (2013)

Cutaneous Hemangiosarcoma in a Dog
por: Tsuji, Naho, et al.
Publicado: (2013)

Hyperferritinemia in Dogs with Splenic Hemangiosarcoma
por: CHIKAZAWA, Seishiro, et al.
Publicado: (2013)

The roles of beta-adrenergic receptors in tumorigenesis and the possible use of beta-adrenergic blockers for cancer treatment: possible genetic and cell-signaling mechanisms
por: quốc Lu’o’ng, Khanh vinh, et al.
Publicado: (2012)

Primary Ureteral Hemangiosarcoma in a dog
por: Polit, Joseph A., et al.
Publicado: (2020)

Primary intrapelvic hemangiosarcoma in a dog
por: YOO, Saejong, et al.
Publicado: (2016)

Spontaneous abdominal hemangiosarcoma in a ferret
por: Nakamura, Shin-ichi, et al.
Publicado: (2019)

Comparison of Serological and Molecular Assays for Bartonella Species in Dogs with Hemangiosarcoma
por: Lashnits, Erin, et al.
Publicado: (2021)

Immunohistochemical detection of a potential molecular therapeutic target for canine hemangiosarcoma
por: ADACHI, Mami, et al.
Publicado: (2015)

Canine hemangiosarcoma in a female Jindo dog
por: Mun, Ahlyum, et al.
Publicado: (2011)

Metastatic hemangiosarcoma of the liver in a young rat
por: Tanaka, Makoto, et al.
Publicado: (2016)

The Role of Hypoxia in 2-Butoxyethanol–Induced Hemangiosarcoma
por: Laifenfeld, Daphna, et al.
Publicado: (2010)

The Role of Beta-Adrenergic Receptors in Depression and Resilience
por: Zhang, Hongxing, et al.
Publicado: (2022)

Characterizing circulating nucleosomes in the plasma of dogs with hemangiosarcoma
por: Wilson-Robles, Heather, et al.
Publicado: (2021)

Tumor-associated macrophages in canine visceral hemangiosarcoma
por: Kerboeuf, Mikael, et al.
Publicado: (2023)

Beta-adrenergic signaling on neuroendocrine differentiation, angiogenesis, and metastasis in prostate cancer progression
por: Zhao, Yicheng, et al.
Publicado: (2019)

Beta(1)-Adrenergic Receptor Cleavage and Regulation by Elastase
por: Zhu, Jing, et al.
Publicado: (2023)

Primary cranial mediastinal hemangiosarcoma in a young dog
por: Yoon, Hun-Young, et al.
Publicado: (2014)

Splenic Hemangiosarcoma in a Young Sprague-Dawley Rat
por: Shiraki, Katsuhisa, et al.
Publicado: (2012)

Spontaneous hemangiosarcoma in the spleen and liver of a young rat
por: Yamane, Rina, et al.
Publicado: (2021)

Hemorrhage and Sudden Death in a Cat with Pancreatic Hemangiosarcoma
por: Toma, Corina, et al.
Publicado: (2022)

Beta-Adrenergic Blockade in Critical Illness
por: Bruning, Rebecca, et al.
Publicado: (2021)

Vulvar and vestibulovaginal hemangiosarcoma in a cow: morphological and histopathological observations
por: Stephan, F., et al.
Publicado: (2022)

Beta adrenergic antagonists and antianginal drugs
por: Stever, Lindsey M., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_rqg1jutq3e85e6igdrkpboeafj